Profiling HRAS Mutations in Adnexal Tumors
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Nottingham University Hospitals NHS Trust
Other organizations : University Hospital of Zurich, University of Bologna, Cleveland Clinic
Variable analysis
- Selection of areas with overgrowth of epithelial or myoepithelial cells based on p63 expression and morphology
- Presence of mutations affecting the HRAS Q61 hotspot locus
- Eight micron-thick FFPE histological sections
- Corresponding p63 IHC stains to highlight the myoepithelium
- Sanger sequencing of the HRAS Q61 hotspot locus
- Positive control: Not specified
- Negative control: Not specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!